Status:
COMPLETED
Comparative Effectiveness of FITs With Colonoscopy
Lead Sponsor:
Barcey T. Levy
Collaborating Sponsors:
University of North Carolina
Texas Tech University Health Sciences Center
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-85 years
Brief Summary
Colorectal cancer is a preventable and/or a treatable cancer, but at least 43% of the United States population is not up-to-date with screening. Although 90% of colorectal cancer screening is done usi...
Detailed Description
Colorectal cancer (CRC) is the third most common cancer and the third leading cause of cancer death in both men and women in the U.S., with nearly 50,000 deaths each year. Since CRC develops over a nu...
Eligibility Criteria
Inclusion
- scheduled for a screening or surveillance colonoscopy
Exclusion
- familial polyposis syndromes: ulcerative colitis or Crohn's disease: or active rectal bleeding
Key Trial Info
Start Date :
October 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
3761 Patients enrolled
Trial Details
Trial ID
NCT03264898
Start Date
October 2 2017
End Date
October 1 2023
Last Update
August 2 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242
2
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
3
Texas Tech University Health Sciences Center
El Paso, Texas, United States, 79924